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Infection with Erysipelothrix rhusiopathiae in swine has a significant economic 
impact on pig production systems worldwide. Since a character zoonotic disease, it poses a problem for public health 
and veterinary services. the clinical and pathological features of the disease have been well-described. Inactivated and 
attenuated vaccines are available to prevent development of clinical signs of swine erysipelas. In Albania, repeatedly 
has had outbreaks in swine erysipelas. For too long in our country has been produced a liquid alive attenuated vaccine 
with  strains VR2. This vaccine has a short validity and cannot be used in any epizootic situation. For these reasons we 
proposed to produce a oily inactivated vaccine, against erysipelas in pigs with a long validity and can be used in any 
situation epizootic. This constitutes also main purpose of this paper. 
 
Introduction  
Swine erysipelas is an important bacterial disease of pigs caused by infection with 
Erysipelothrix rhusiopathiae. Since a character zoonotic disease, it poses a problem for public 
health and veterinary services. the clinical and pathological features of the disease have been well-
described (Wood and Henderson, 2006). Swine erysipelas found in literature in different languages 
such as Schweinerotlauf, Vlekziekte, Rouget du porc, Mal Rossino, erysipelas del cerdo, etc. 
Causative agent of swine erysipelas is Erysipelothrix rhusiopathiae. In 1876 Erysipelothrix 
muriseptica was isolated from  the blood of a mouse with septicemia by Koch. In 1966, the name 
was changed to E. rhusiopathiae.    
 
The genus Erysipelothrix is now subdivided  into two major species, E. rhusiopathiae 
(Migula 1900; Skerman et al. 1980) and Erysipelothrix tonsillarum (Takahashi et al. 1987). In 
addition, there are other strains that constitute one or more additional species currently known as 
Erysipelothrix sp.-1 (Takahashi et al. 1992, 2008), Erysipelothrix sp.-2 (Takahashi et al. 1992, 
2008), Erysipelothrix inopinata (Verbarg et al. 2004), and Erysipelothrix sp.-3 (Takahashi et al. 
2008). Erysipelothrix spp. strains can be differentiated by precipitation reactions using 
hyperimmune rabbit antiserum into at least 28 serotypes (Kucsera 1973; Wood and Harrington 
1978). Field cases of swine erysipelas throughout the world are predominantly caused by E. 
rhusiopathiae serotypes 1a, 1b, or 2, while less common serotypes of E. rhusiopathiae typically 
have lower virulence for swine.  The organism is presented in the form of rods, straight, angled, in 
the form of the letter "V" or "X" or spiral with 0.2-0.4 x 0.8-2.5µ.  
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Erysipelothrix spp. is a gram positive microorganism Erysipelothrix are nonmotile, 
nonsporulating, non-acid-fast, slender gram-positive rods (Brooke and Riley 1999).  All the 
members of the genus are facultative anaerobes and grow between 5°C and 44°C, with optimal 
growth occurring between 30°C and 37°C (Brooke and Riley 1999; Carter 1990; Sneath et al. 
1951). 
The causative organism of swine erysipelas, Erysipelothrix rhusiopathiae, was first 
isolated from a pig in 1882 by Louis Pasteur. In 1885, E. rhusiopathiae was isolated from pigs in 
the United States (Smith 1885). 
 
Prevention of swine erysipelas is best accomplished by immunization programs. Current 
vaccines are based on E. rhusiopathiae serotypes 1 or 2 and are either inactivated bacterins for 
intramuscular injection or attenuated (avirulent live) vaccines designed for whole herd mass 
treatment via drinking water (Jeffrey J. Zimmerman. 2012) Most bacterins are serotype 2 (Eamens 
et al. 2006; Wood 1979) and most attenuated live vaccines contain serotype 1a isolates (Opriessnig 
et al. 2004). 
 
For the prevention of this disease in pigs in our country used a live attenuated vaccine. Its 
practical application has some difficulties. This vaccine is applied only in swine herds free from 
disease. In herds where infection has erupted, the application of this vaccine aggravate the 
situation. The assessment of effectiveness of its carried out only on animals homologue, 
consequently has a high financial cost. In order to improve the parameters of this vaccine we 
undertook the study with the above title. 
 
Materials and Methods 
 
The study of biological properties of strains of Erysipelothrix rhusiopathiae avaiable was conducted 
by test Spearman – Karber. The study of biological properties of the strains was conducted on white 
mouse weighing 18-20 grams as follows:  
 
From 24-hour bacterial cultures of each strain of E. rhusiopathiae became the dilutions up to 10-6 
dilution (acting according to the classic model of dilution 9 + 1). With each dilution was injected into the 
subcutaneous route 7 groups of rats, the 5 heads of each group. 
 
Calculation of the Lethal Dose 
 
To calculate the dose Letale 50% was used statistical methods Reed –Muench. At first it calculates the 
distance proportional (DP) between the dilution that gives a percentage over 50% and that gives a 
percentage of infected under 50%. 
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Production of Emulsions of Vaccines 
By bottles containing vaccine, strains selected by Dose Letale 50%, were carried out 
planting in the solid terrains agar, liquid terrain and Taroc terrain. Then, the bacterial cultures were 
placed in incubator for incubation for 24 hours at temperature 37
o
C. After incubation, the cultures 
were pulled from the incubator and were controled macroscopically and microscopically for 
purity.  After control for purity with each of the selected strains were planted by 10 plates Roux. 
Roux plates were placed in incubation at 37
o
C for 24 hours. After incubation plates were pulled 
from the thermostat and were controlled for purity (macroscopically). Plates were washed with 
water physiological at concentration 0.5% formol. For each strain were collected separately base 
emulsions and were placed in thermostat at 37
o
C to population bacterial killing. To verify the 
killing of this bacterial population, 0.1 ml of each solution was planted on solid agar terrain and 
the terrain Taroc in the interval 3, 5, 6 and 7 days. Bacterial emulsions were considered killed 
when cultural terrains mentioned above remained sterile. Emulsions were controlled for their 
microbial concentration by means of Mac Ferland optical standard (dilution based 1/10). For 
determining the microbial concentration through optical standard Mac Ferland were conducted for 
each emulsion dilutions 1/10, 1/100, 1/150, 1/200, 1/250, 1/300, which was leveled the score at 
with optical standard. Vaccine emulsions were corrected so that 1 ml emulsion have a microbial 
concentration of 3 billion.  
Determining the quality of oily protective vaccine against swine Erysipelothrix in 
laboratory animals (white mouse) 
 
To determine the protective power of the vaccine was injected sub Cutaneous by 0.5 ml 
vaccine white mouse divided into 14 groups, each group was formed by 5 heads. After 21 days 
and 6 months after vaccination, the vaccinated mouse were infected in parallel with the other 30 
mouse not been vaccinated with 0.5 ml virulent strain liquid culture RS C 43-8, and its dilution. 
The difference of DL 50% resulting between mice vaccinated and infected, and them to control 
gave the protective power of the vaccine expressed in logarithmic scale. As oily adjuvant was used 
Marcol 52 and Arlacel 80. It was determined the ratio of oil adjuvant (Marcol 52 and Arlacel 80) 
with emulsion of vaccine 9:1. It produced a vaccine with  oily adjuvant  at a concentration of 3 
billion microbial cells per ml 
 
Results and Discussion 
 
With oily adjuvant  vaccine were vaccinated 35 mouse in 0.5 ml dose, subcutaneous. After 
21 days after vaccination, the vaccinated mouse were infected in parallel with the other 30 mouse 
not been vaccinated with 0.5 ml virulent strain liquid culture RS C 43-8, and its dilution. The data 
are presented in table n
o
 1 
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Table 1: Determination of the protective power of oily adjuvant vaccine against swine 
erysipelas in laboratory animals (white mouse), 21 days after vaccination 
 
Type of 
vaccine 
   
Heads 
vaccinated  
Dose of 
vaccine  
 Infected after 21 days post vaccination  protection 
Infected 
with  
Infected 
heads  
Dead after 
infection 
Alive after 
infection 
Ratio  
N/ Total  
 
Vaccine with 
oily adjuvant 
   
 5  
 5  
 5  
 5  
 5  
 5  
 5  
0.5ml  
 ―  
 ―  
 ―  
 ―  
 ―  
 ―  
0.5ml 
culture  
0.5 ml 10-1  
0.5 ml 10-2  
0.5 ml 10-3  
0.5 ml 10-4  
0.5 ml 10-5  
0.5 ml 10-6  
5 
5 
5 
5 
5 
5 
5 
  5  
  5  
  5  
  5  
  1  
  0  
  0  
0 
0 
0 
0 
4 
5 
5 
5/5 
5/5 
5/5 
5/5 
1/5 
0/5 
0/5 
DL 50 % is 0.5 
ml of dilution 
10-3.68  
Heads non 
vaccinated 
(control)  
0.5 ml 10-1 
0.5 ml 10-2  
0.5 ml 10-3  
0.5 ml 10-4  
0.5 ml 10-5  
0.5 ml 10-6  
  5  
  5  
  5  
  5  
  5  
  5  
  5  
  5  
  5  
  5  
  2  
  0  
    0  
    0  
    0  
    0  
    3  
    5  
5/5  
5/5  
5/5  
5/5  
2/5  
0/5  
DL 50 % is 
0.5 ml of 
dilution 10-
4.83  
5/5  
5/5  
5/5  
5/5  
2/5  
0/5  
0.5 ml 10-1  
0.5 ml 10-2  
0.5 ml 10-3  
0.5 ml 10-4  
0.5 ml 10-5  
0.5 ml 10-6  
 
Difference between DL 50% of the mouse  vaccinated  and their unvaccinated with oily 
adjuvant  vaccine gave protective power of the vaccine against swine erysipelas, which was 1:15 
logarithmic scale, protection. This is considered nearly over 20 lethal minimal dose.  
 
In table 2 shows the data of the control power protective of  vaccine after a period of 6 
months. 
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Table 2: Determination of the protective power of oily adjuvant vaccine against swine 
erysipelas in laboratory animals (white mouse), 6 months after vaccination. 
 
Type of 
vaccine 
Vaccinated 
heads 
Dose  
of 
vaccine 
Infected after 6 month post vaccination  
Infected with Infected 
heads 
Dead after 
infection 
Alive 
after 
infection 
Ratio  
N/ Total 
Oily 
adjuvant 
vaccine 
  5 
  5 
  5 
  5 
  5 
  5 
  5 
0.5 ml  
 ― 
 ― 
 ― 
 ― 
 ― 
 ― 
0.5 ml culture 
0.5 ml 10-1 
0.5 ml 10-2 
0.5 ml 10-3 
0.5 ml 10-4 
0.5 ml 10-5 
0.5 ml 10-6 
    5 
    5 
    5 
    5  
    5 
    5 
    5 
      5 
      5 
      5 
      5 
      4 
      1 
      0 
  0 
  0 
  0 
  0 
  1 
  4 
  5 
5/5 
 5/5 
 5/5 
 5/5 
 4/5 
 1/5 
 0/5 
DL 
50% is 
0.5 ml 
of 
dilution 
10-4.54 
Heads unvaccinated (control group) 0.5 ml 10-1 
0.5 ml 10-2 
0.5 ml 10-3 
0.5 ml 10-4 
0.5 ml 10-5 
0.5 ml 10-6 
    5 
    5 
    5 
    5 
    5 
    5 
      5 
      5 
      5 
      5 
      2 
      0 
  0 
  0 
  0   
  0 
  3 
  5        
5/5 
 5/5 
 5/5 
 5/5 
 2/5 
 0/5 
DL 50 
% is 0.5 
ml of 
dilution  
10-4.83 
 
 
Difference between DL 50% of vaccinated mice with unvaccinated gave the protective 
power of the oily adjuvant  vaccine against swine erysipelas, which is 0:29 logarithmic scale, 
which is considered the protection of minimal lethal dose nearly of 2,9. We believe that the 
protective effect of the vaccine is good, and should be used in specific prophylaxis against this 
infection. 
 
Conclusion 
 
Was produced oily adjuvant vaccine against swine erysipelas with a one year shelf life. 
Protective power of the vaccine in laboratory animals 21 and 180 days after vaccination were 
respectively 1:15 and 0:29 DL 50%. Oily vaccine produced by us can be used in any epizootic 
situation.  
 
 
 Page | 86  
Anglisticum Journal (AJ), Volume: 6 | Issue: 1, January 2017 |  
 
 Volume 6, issue 1, 2017  e-ISSN: 1857-8187   p-ISSN: 1857-8179                                                                                                            
References  
 
1. Brooke CJ, Riley TV. 1999. J Med Microbiol 48:789–799. 
2. Carter GR. 1990. Erysipelothrix rhusiopathiae. In JR Cole, ed. Diagnostic Procedures in 
Veterinary Microbiology and Mycology, 5th ed. Springfield, IL: Academic Press, pp. 195–196. 
3. Eamens GJ, Chin JC, Turner B, Barchia I. 2006. Vet Microbiol 116: 138–148. 
4. G Ueberschar S, Weiss R and Winklemann J. 1977. Pathogenetische Bedeutung von 
Erysipelothrix rhuisiopathiae in der acuten und chronischen Verlaufsform der Rotlaufarthritis. 
DTW 84: 107-111. 
5. Jeffrey J. Zimmerman et al. 2012. Swine diseases 10
th
 edition, p 750-760 
6. Migula W. 1900. System der Bakterien, Vol. 2. Jena, Germany: Gustav Fischer 
7. Opriessnig T, Bender JS, Halbur PG. 2010. J Vet Diagn Invest 22:86–90. 
8. Schulz LC, Drommer W, Seidler D, et al. 1975a. Beitr Pathol 154:27–51. -- 1975b. Beitr Pathol 
154:1–26. 
9. Skerman VBD, McGowan V, Sneath PHA. 1980. Int J Syst Bacteriol 30:225–420 
10. Shuman R. D. 1951. Swine erysipelas induced by skin scarification. Proc Am vet Med Assoc, 
p. 153. 1959. Comparative experimental evaluation of swine erysipelas bacterins and vaccines in 
weanling pigs, with particular reference to the status of their dams. Am J Vet Res 20:1002-1009 
11. Smith T. 1885. Second Annual Report of the Bureau of Animal Industry. Washington. D.C.: 
USDA, p. 187. 
12. Sneath PH, Abbott JD, Cunliffe AC. 1951. Br Med J 2: 1063–1066. 
13. Takahashi T, Fujisawa T, Tamura Y, et al. 1992. Int J Syst Bacteriol 42:469–473. 
14. Verbarg S, Rheims H, Emus S, et al. 2004. Int J Syst Evol Microbiol 54:221–225. 
15. Wood R L, Henderson L M, 2006. Erysipelas. In: Straw B. E, Zimmerman, J J D‘Allaire, S, 
Taylor D J. (Eds.), Diseases of Swine. Blackwell Publishing Professional, Ames, Iowa, USA, pp. 
629–638. 
16. Wood RL, Harrington R Jr. 1978. Am J Vet Res 39:1833–1840. 
 
 
 
 
 
